Vcp overexpression and leucine supplementation extend lifespan and ameliorate neuromuscular junction phenotypes of a SOD1G93A-ALS mouse model

Tzyy-Nan Huang,Yu-Tzu Shih,Tzu-Li Yen,Yi-Ping Hsueh

DOI: https://doi.org/10.1093/hmg/ddae022

IF: 5.1214

2024-02-21

Human Molecular Genetics

Abstract:Abstract Many genes with distinct molecular functions have been linked to genetically heterogeneous amyotrophic lateral sclerosis (ALS), including SuperOxide Dismutase 1 (SOD1) and Valosin-Containing Protein (VCP). SOD1 converts superoxide to oxygen and hydrogen peroxide. VCP acts as a chaperon to regulate protein degradation and synthesis and various other cellular responses. Although the functions of these two genes differ, in the current report we show that overexpression of wild-type VCP in mice enhances lifespan and maintains the size of neuromuscular junctions (NMJs) of both male and female SOD1G93A mice, a well-known ALS mouse model. Although VCP exerts multiple functions, its regulation of ER formation and consequent protein synthesis has been shown to play the most important role in controlling dendritic spine formation and social and memory behaviors. Given that SOD1 mutation results in protein accumulation and aggregation, it may direct VCP to the protein degradation pathway, thereby impairing protein synthesis. Since we previously showed that the protein synthesis defects caused by Vcp deficiency can be improved by leucine supplementation, to confirm the role of the VCP-protein synthesis pathway in SOD1-linked ALS, we applied leucine supplementation to SOD1G93A mice and, similar to Vcp overexpression, we found that it extends SOD1G93A mouse lifespan. In addition, the phenotypes of reduced muscle strength and fewer NMJs of SOD1G93A mice are also improved by leucine supplementation. These results support the existence of crosstalk between SOD1 and VCP and suggest a critical role for protein synthesis in ASL. Our study also implies a potential therapeutic treatment for ALS.

genetics & heredity,biochemistry & molecular biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the interaction between two genes related to amyotrophic lateral sclerosis (ALS) - superoxide dismutase 1 (SOD1) and valosin - containing protein (VCP), and to evaluate the impact of these interactions on ALS mouse models. Specifically, the researchers explored this problem through the following two aspects: 1. **VCP over - expression**: The researchers over - expressed VCP in SOD1 G93A - mutated mice to observe whether this treatment could prolong the lifespan of the mice and improve the phenotype of their neuromuscular junctions (NMJ). SOD1 G93A - mutated mice are a commonly used ALS model, which simulates some pathological features of human ALS patients. 2. **Leucine supplementation**: The researchers also tested whether leucine supplementation through drinking water could improve the survival time and muscle strength of SOD1 G93A - mutated mice, and whether it could increase the area of NMJ. Leucine is a branched - chain amino acid known to activate the mTOR pathway and thus promote protein synthesis. The main hypothesis of the paper is that SOD1 mutation not only leads to protein aggregation and accumulation, but may also indirectly reduce protein synthesis by guiding VCP to the protein degradation pathway, thereby affecting neuronal function. Therefore, increasing protein synthesis through VCP over - expression or leucine supplementation can improve the phenotype of SOD1 G93A - mutated mice, which may provide a new strategy for the treatment of ALS. Through these experiments, the researchers aim to reveal the importance of protein synthesis in the pathogenesis of ALS and explore potential treatment methods.

Vcp overexpression and leucine supplementation extend lifespan and ameliorate neuromuscular junction phenotypes of a SOD1G93A-ALS mouse model

The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model

Subpial delivery of adeno-associated virus 9-synapsin-caveolin-1 (AAV9-SynCav1) preserves motor neuron and neuromuscular junction morphology, motor function, delays disease onset, and extends survival in hSOD1G93A mice

Overexpression of autophagy enhancer PACER/RUBCNL in neurons accelerates disease in the SOD1G93A ALS mouse model

Up-regulation of cholesterol synthesis pathways and limited neurodegeneration in a knock-in Sod1 mutant mouse model of ALS

Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation

Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis

SERCA1 Overexpression in Skeletal Muscle Attenuates Muscle Atrophy and Improves Motor Function in a Mouse Model of ALS

Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions

In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model

Activation of autophagy attenuates motor deficits and extends lifespan in a C. elegans model of ALS

Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the Copper-Chaperone-for-SOD

A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity

Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis

A combinatorial approach to ALS therapies in the PrP.TDP43-315 model of ALS; complications and tribulations

PROTECTIVE EFFECTS OF RESVERATROL ON THE MUTANT hSOD1G93A-BEARING MOTOR NEURON-LIKE CELL CULTURE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS THROUGH THE UPREGULATION OF SIRT1 EXPRESSION

Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice

Aberrant DNA and RNA Methylation Occur in Spinal Cord and Skeletal Muscle of Human SOD1 Mouse Models of ALS and in Human ALS: Targeting DNA Methylation Is Therapeutic

RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS mice

Neuronal overexpression of potassium channel subunit Kcnn1 prolongs survival of SOD1-linked ALS and A53T alpha-synuclein mouse models

Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons